Houston innovators podcast episode 97

How this entrepreneur is preparing Houston for the future of electric vehicles

David Aaronson of REVS shares his EV entrepreneurial journey on the Houston Innovators Podcast. Photo courtesy of REVS

If you live in Texas and you drive an electric vehicle, you probably own a home — mostly because homeowners have a place to safely charge their vehicle. Apartment dwellers don't have that option in most residences. But David Aaronson is trying to change that.

Aaronson, a Houston real estate veteran, founded Refuel Electric Vehicle Solutions, or REVS, last year to become the go-between for multifamily property owners and managers and the charging technology providers. Basically, Aaronson, a reseller for EV charging ports, is targeting multifamily companies and brokering the deal to install one or two charging ports now — as well as supporting scalability for when even more EVs hit the Texas roads.

"It's a new industry," Aaronson says on this week's episode of the Houston Innovators Podcast. "You have the manufacturers who are all so busy — they really don't have the time to find new business."

So REVS picks up the slack to provide a service that's only going to grow in demand. On his plate right now is educating his clients and potential clients.

"We find that with everyone we run into, there's an education process," he explains.

From what types of technology is available to whether or not the property is even equipped with enough electricity to support a charging station, Aaronson says he has to go through this process with everyone. Another challenge he faces is his potential clients not seeing the benefits at the moment. He says some of the property managers want to kick the can down the road, so to speak, but that road is getting shorter and shorter.

EVolve Houston, founded in part by the city, predicts that EV sales locally will make up 30 percent of annual new car sales by 2030. Aaronson says they reported that Houston has around 15,000 EVs on the road today, but by 2030, that's going to be 600,000.

"If it's not 2030 it's going to be 2032, because it's all the manufacturers are making," Aaronson says. "It's just a matter of time."

By installing the equipment, Aaronson says he's offering multifamily property owners a new revenue stream because tenants will pay to use the charging station. Plus, it's a perk that can be a dealbreaker for future residents.

"If you just have one person driving an electric vehicle that doesn't lease at your apartment because you don't have a station, you've lost money," he says on the show.

Aaronson explains he got into this new business that he now has such a passion for, as well as how how he's excited to grow his company alongside the growth of EVs and their necessary infrastructure on the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Trending News

Building Houston

 
 

From a low-cost vaccine to an app that can help reduce exposure, here are the latest COVID-focused and Houston-based research projects. Photo via Getty Images

While it might seem like the COVID-19 pandemic has settled down for the time being, there's plenty of innovative research ongoing to create solutions for affordable vaccines and tech-enabled protection against the spread of the virus.

Some of that research is happening right here in Houston. Here are two innovative projects in the works at local institutions.

UH researcher designs app to monitor best times to shop

A UH professor is putting safe shopping at your fingertips. Photo via UH.edu

When is the best time to run an errand in the pandemic era we currently reside? There might be an app for that. Albert Cheng, professor of computer science and electrical and computer engineering at the University of Houston, is working on a real-time COVID-19 infection risk assessment and mitigation system. He presented his plans at the Institute of Electrical and Electronics Engineers conference HPC for Urgent Decision Making and will publish the work in IEEE Xplore.

Cheng's work analyzes up-to-date data from multiple open sources to see when is the best time to avoid crowds and accomplish activities outside the home.

"Preliminary work has been performed to determine the usability of a number of COVID-19 data websites and other websites such as grocery stores and restaurants' popular times and traffic," Cheng says in a UH release. "Other data, such as vaccination rates and cultural factors (for example, the percentage of people willing to wear facial coverings or masks in an area), are also used to determine the best grocery store to shop in within a time frame."

To use the app, a user would input their intended destinations and the farthest distance willing to go, as well as the time frame of the trip. The risk assessment and mitigation system, or RT-CIRAM, then "provides as output the target location and the time interval to reach there that would reduce the chance of infections," said Cheng.

There's a lot to it, says Cheng, and the process is highly reliant on technology.

"We are leveraging urgent high-performance cloud computing, coupled with time-critical scheduling and routing techniques, along with our expertise in real-time embedded systems and cyber-physical systems, machine learning, medical devices, real-time knowledge/rule-based decision systems, formal verification, functional reactive systems, virtualization and intrusion detection," says Cheng.

2 Houston hospitals team up with immunotherapy company for new vaccine for Africa

The new vaccine will hopefully help mitigate spread of the disease in Sub-Saharan Africa. Photo via bcm.edu

Baylor College of Medicine and Texas Children's Hospital have teamed up with ImmunityBio Inc. — a clinical-stage immunotherapy company — under a licensing agreement to develop a safe, effective and affordable COVID-19 vaccine.

BCM has licensed out a recombinant protein COVID-19 vaccine candidate that was developed at the Texas Children's Hospital Center for Vaccine Development to ImmunityBio. According to the release, the company engaged in license negotiations with the BCM Ventures team, about the vaccine that could address the current pandemic needs in South Africa.

"We hope that our COVID-19 vaccine for global health might become an important step towards advancing vaccine development capacity in South Africa, and ultimately for all of Sub-Saharan Africa," says Dr. Peter Hotez, professor and dean of the National School of Tropical Medicine at Baylor and co-director of the Texas Children's Hospital Center for Vaccine Development.

ImmunityBio, which was founded in 2014 by Dr. Patrick Soon-Shiong, is working on innovative immunotherapies that address serious unmet needs in infectious diseases, according to a news release from BCM.

"There is a great need for second-generation vaccines, which are accessible, durable and offer broad protection against the emerging variants," says Soon-Shiong. "ImmunityBio has executed on a heterologous ("mix-and-match") strategy to develop a universal COVID-19 vaccine. To accomplish this, we have embarked upon large-scale good manufacturing practices and development of DNA (adenovirus), RNA (self-amplifying mRNA) and subunit protein (yeast) vaccine platforms. This comprehensive approach will leverage our expertise in these platforms for both infectious disease and cancer therapies."

Trending News